Metabolism, Excretion, and Pharmacokinetics of [14C]-Radiolabeled Aleglitazar: A Phase I, Nonrandomized, Open-Label, Single-Center, Single-Dose Study in Healthy Male Volunteers

Autor: Sturm, Stefan, Seiberling, Michael, Weick, Idelette, Paehler, Axel, Funk, Christoph, Ruf, Thorsten
Zdroj: In Clinical Therapeutics February 2012 34(2):420-429
Databáze: ScienceDirect